Novo Nordisk's Wegovy cuts risk of heart attack, stroke by 20%, study finds
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say
Source: marketwatch.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Anna Windle. Real-time updates on events, politics, business and more.